Multimodal Imaging

Multimodal Imaging Market by Product (Multimodal Imaging Equipment, Reagents, Software), Technology (PET/CT, PET/MRI, SPECT/CT), Application, End User - Global Forecast 2024-2030

360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the multimodal imaging market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[187 Pages Report] The Multimodal Imaging Market size was estimated at USD 2.83 billion in 2023 and expected to reach USD 3.00 billion in 2024, at a CAGR 6.18% to reach USD 4.30 billion by 2030.

Multimodal Imaging Market
To learn more about this report, request a free PDF copy

Multimodal imaging encompasses developing, producing, distributing, and utilizing advanced imaging technologies that combine two or more imaging modalities within a single device or system.The rising focus on early diagnosis of chronic diseases, technological advancements, an aging global population with age-related ailments increases the use of multimodal imaging. However, multimodal imaging systems' high acquisition and maintenance costs may hinder widespread adoption, especially in emerging economies with limited healthcare budgets. Nevertheless, AI-powered algorithms are expected to help streamline data analysis from multiple modalities simultaneously improving diagnostic accuracy while reducing processing time.

Multimodal Imaging Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Product: Increasing demand for multimodal imaging equipments for disease diagnostics

Multimodal imaging equipment employs multiple modalities such as computed tomography (CT), optical coherence tomography (OCT), magnetic resonance imaging (MRI), ultrasound positron emission tomography (PET) to capture detailed images of various biological tissues and structures. Reagents play a crucial role in multimodal imaging by enhancing the contrast between different tissues in the body or highlighting specific molecular targets related to diseases. Some common reagents used in multimodal imaging are radioisotopes for PET/Single photon emission computed tomography (SPECT) scans, gadolinium-based contrast agents for MRI, iodinated compounds for CT scans, and fluorescent dyes for optical imaging. Software solutions in multimodal imaging enable the acquisition, processing, analysis, and visualization of data from different imaging modalities. Multimodal imaging software is essential when dealing with complex diseases requiring the integration of images from various modalities.

Application: Expanding use of multimodal imaging for oncology

In cardiology applications, multimodal imaging provides healthcare professionals with detailed information regarding cardiac tissue structure, function, and perfusion. Some prominent imaging techniques include echocardiography, nuclear cardiology, and cardiac magnetic resonance imaging (MRI). Clinical applications encompass various medical disciplines that utilize multimodal imaging to enhance diagnosis, treatment planning, and disease monitoring. Techniques such as computed tomography (CT), MRI, positron emission tomography (PET), and ultrasound are employed in diverse clinical settings, including orthopedics, gastroenterology, gynecology, and pediatrics. In neurology applications, multimodal imaging is vital in understanding brain function and diagnosing neurological disorders such as Alzheimer's or multiple sclerosis by combining structural data with functional information. Oncologic multimodal imaging has significance in early detection of cancer, monitoring treatment response, and identifying recurrence post-therapy

Technology: Significant applications of PET/CT technology owing to its high sensitivity and specificity

Positron Emission Tomography/Computed Tomography (PET/CT) is an imaging technique that combines the functional information from PET with the anatomical details of CT. It is utilized in oncology, cardiology, and neurology applications for diagnosis, staging, and assessment of treatment response. Moreover, PET/Magnetic Resonance Imaging (PET/MRI) is a hybrid technology combining the metabolic information obtained from PET with the high-resolution soft tissue contrast provided by MRI. This modality benefits pediatric oncology, brain imaging for neurodegenerative diseases, and cardiovascular imaging. Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) is a versatile hybrid imaging modality that combines functional SPECT data with anatomical CT information. It is primarily employed in orthopedic, cardiac, and oncological imaging.

End-User: Proliferating demand for multimodal imaging in diagnostic centers

Academic and research institutes use multimodal imaging technology as they need advanced tools to offer better insights into various biological processes. It enables researchers to study intricate cellular structures, molecular interactions, and disease pathology with high-resolution images. Diagnostic centers provide crucial diagnostic services, including radiology, ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), nuclear medicine (NM), optical coherence tomography (OCT), and positron emission tomography (PET) scans. The increased chronic illness and the growing geriatric population have raised the need for advanced imaging systems in hospital settings.

Regional Insights

In the United States and Canada, there has been a rising demand for advanced diagnostic tools due to an aging population and surge in prevalence of chronic diseases. Investments in research and development have led to numerous patents being filed, showcasing innovation in this sector. European Union countries have also seen growth in the multimodal imaging market with increasing collaboration between academia, clinical institutions, and industry players driving innovation. In the Middle East and Africa region, improving healthcare infrastructure has created a significant growth opportunities multimodal imaging market. Governments are investing in healthcare to address the rising incidences of non-communicable diseases such as cancer and cardiovascular disorders where advanced imaging plays a crucial role. China, Japan, India, and other Asia Pacific countries are experiencing robust expansion of their multimodal imaging markets due to factors such as rapid urbanization, expanding healthcare facilities, and increasing disposable income.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Multimodal Imaging Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Multimodal Imaging Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Renovaro Biosciences to Acquire Multiomic, Multimodal AI Bioinformatics Startup Gedi Cube

    Gedi Cube, an Amsterdam-based AI and machine learning firm, has announced its acquisition by Renovaro Biosciences. The acquisition by Renovaro positions Gedi Cube for potential entry into the US market and the opportunity to conduct its first clinical trial within a year. [Published On: 2023-09-29]

  • nference and Vanderbilt University Medical Center Sign Agreement to Advance Real-World Evidence Generation in Complex Disease Populations

    nference, a science-first software company in healthcare, and Vanderbilt University Medical Center (VUMC), an academic medical center, have entered into a strategic agreement to advance research. This collaboration combines VUMC's multi-modal data with nference's federated AI platform, allowing for the expansion of clinical insights in key research areas. By leveraging multimodal data, including imaging and digital pathology, this agreement will provide researchers with diverse datasets that are crucial for understanding patient needs. [Published On: 2023-07-25]

  • Funding for Correlated Multimodal Imaging projects from COMULISglobe

    CZI-funded COMULISglobe project that aims to establish a collaborative multi-modal imaging network between biological and clinical research. The project offers two grant schemes: Global Showcases and Lab Exchanges/Mobility Grants. These grants are designed to support multi-modal imaging initiatives across different countries. [Published On: 2023-06-12]

Key Company Profiles

The report delves into recent significant developments in the Multimodal Imaging Market, highlighting leading vendors and their innovative profiles. These include Bruker Corporation, Canon Inc., GE Healthcare, Infraredx Inc., International Business Machines Corporation, Koninklijke Philips N.V., Mediso Ltd., MR Solutions Ltd., Neusoft Medical Systems Co., Ltd., Northridge Tri-Modality Imaging, Inc., PerkinElmer, Inc., Shanghai United Imaging Healthcare Co., Ltd., Siemens AG, Spectrum Dynamics Medical, Inc., and Topcon Corporation.

Market Segmentation & Coverage

This research report categorizes the Multimodal Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Multimodal Imaging Equipment
    • Reagents
    • Software
  • Technology
    • PET/CT
    • PET/MRI
    • SPECT/CT
  • Application
    • Cardiology
    • Clinical Applications
    • Neurology
    • Oncology
  • End User
    • Academic & Research Institutes
    • Diagnostic Centers
    • Hospital

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Multimodal Imaging Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Multimodal Imaging Market?
  3. What are the technology trends and regulatory frameworks in the Multimodal Imaging Market?
  4. What is the market share of the leading vendors in the Multimodal Imaging Market?
  5. Which modes and strategic moves are suitable for entering the Multimodal Imaging Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Multimodal Imaging Market, by Product
  7. Multimodal Imaging Market, by Technology
  8. Multimodal Imaging Market, by Application
  9. Multimodal Imaging Market, by End User
  10. Americas Multimodal Imaging Market
  11. Asia-Pacific Multimodal Imaging Market
  12. Europe, Middle East & Africa Multimodal Imaging Market
  13. Competitive Landscape
  14. Competitive Portfolio
  15. List of Figures [Total: 24]
  16. List of Tables [Total: 378]
  17. List of Companies Mentioned [Total: 15]
Understanding the Technical Advancements in Multimodal Imaging
October 9, 2023
BLOG
Understanding the Technical Advancements in Multimodal Imaging
Medical technology has always played a significant role in diagnosing and treating medical conditions. One such advancement that has revolutionized medical imaging is multimodal imaging. Multimodal imaging combines two or more imaging techniques to create a comprehensive and accurate diagnosis of medical conditions. Over the years, multimodal imaging has undergone various technical advancements. In this blog, we will explore these advancements and their benefits.

Integration of Multiple Modalities:

Multimodal imaging involves combining two or more imaging modalities, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT), to overcome the limitations of individual imaging modalities. One significant advancement in multimodal imaging technology is the integration of multiple modalities into a single imaging system, making diagnoses more accurate and efficient.

Advanced Image Processing Techniques:

The development of advanced image processing techniques has also contributed to the technical advancements in multimodal imaging. Image processing algorithms can help fuse images from different modalities, remove artifacts, and improve image quality. In this manner, healthcare professionals can access detailed body images, assisting in identifying abnormalities and enhancing the diagnostic process.

Improved Resolution and Contrast:

Due to technological advancements, the resolution and contrast of multimodal imaging have improved over the years. High-resolution images provide a detailed view of internal organs, tissues, and structures, aiding in detecting even minute anomalies in the body and allowing for more accurate diagnosis and treatment.

Incorporation of Artificial Intelligence (AI):

Another exciting development in multimodal imaging technology is incorporating artificial intelligence (AI). AI algorithms can identify anatomic structures and significant landmarks in medical images, which can aid in detecting abnormalities that a manual evaluation can miss. AI also helps to automate image processing, reducing the time and effort required to generate high-resolution images.

Improved Clinical Decision-Making and Better Outcomes:

With these advancements in multimodal imaging, clinicians can analyze more comprehensive and accurate images, providing valuable insights into diagnosing medical conditions. Such advanced image analyses can help facilitate medical decision-making while reducing the risk of invasive procedures and increasing the efficacy of treatments, improving patient outcomes.

Technical advancements in multimodal imaging have significantly transformed the field of medical imaging. Integrating different imaging modalities, advanced image processing techniques, improved resolution and contrast, and incorporation of AI have all contributed to enhanced medical decision-making and improved patient outcomes.

Frequently Asked Questions
  1. How big is the Multimodal Imaging Market?
    Ans. The Global Multimodal Imaging Market size was estimated at USD 2.83 billion in 2023 and expected to reach USD 3.00 billion in 2024.
  2. What is the Multimodal Imaging Market growth?
    Ans. The Global Multimodal Imaging Market to grow USD 4.30 billion by 2030, at a CAGR of 6.18%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.